1887

Abstract

Cytotoxic T lymphocyte (CTL) responses to vaccinia virus (VV) were studied in human subjects receiving smallpox vaccine by dermal scarification. After restimulation with VV, peripheral blood mononuclear cells (PBMCs) from three of six vaccinated subjects killed virus-infected target cells. VV-specific, HLA-restricted CTL activity was mediated primarily by CD8 cells, although low levels of lytic activity by CD4 cells were observed in some experiments. Two of the three responders had no history of exposure to VV prior to vaccination, whereas all three non-responders were vaccinated against smallpox during childhood. PBMCs from an additional three subjects who had received smallpox vaccine at least 20 years previously were negative for CTL activity. These data suggest that the duration of memory CTL populations against VV in the peripheral blood is limited, and that pre-existing immunity to VV may interfere with boosting of the CTL response upon revaccination.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-4-751
1993-04-01
2022-01-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/4/JV0740040751.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-4-751&mimeType=html&fmt=ahah

References

  1. Anonymous. 1980; Recommendation of the immunization practices advisory committee (ACIP): smallpox vaccine. Morbidity and Mortality Weekly Report 29:417–120
    [Google Scholar]
  2. Bennink J. R., Yewdell J. R. 1990; Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Current Topics in Microbiology and Immunology 163:154–184
    [Google Scholar]
  3. Brunner K. T., Mauel J., Cerottini J. C., Chapuis B. 1968; Quantitative assay of the lytic action of immune lymphoid cells on 51Cr labeled allogeneic target cells in vitro: inhibition by isoantibody and by drugs. Immunology 14:181–196
    [Google Scholar]
  4. Cooney E. L., Collier A. C., Greenberg P. D., Coombs R. W., Zarling J., Arditti D. E., Hoffman M. C., Hu S. L., Corey L. 1991; Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337:567–572
    [Google Scholar]
  5. Germain R. N. 1986; The ins and outs of antigen presentation. Nature, London 322:687–689
    [Google Scholar]
  6. Graham S., Green C. P., Mason P. D., Borysiewicz L. K. 1991; Human cytotoxic T cell responses to vaccinia virus vaccination. Journal of General Virology 72:1183–1186
    [Google Scholar]
  7. Hickling J. K., Borysiewicz L. K., Sissons J. GP. 1986; Varicella-zoster virus specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. Journal of Virology 61:3463–3469
    [Google Scholar]
  8. Kannagi M., Sugamura K., Sato H., Okochi K., Uchino H., Hinuma Y. 1983; Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. Journal of Immunology 130:2942–2946
    [Google Scholar]
  9. Littaua R. A., Takeda A., Cruz J., Ennis F. A. 1992; Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones. Journal of Virology 66:2274–2280
    [Google Scholar]
  10. McMichael A. J., Dongworth D. W., Gotch F. M., Clark A. 1983; Declining T-cell immunity to influenza, 1977-82. Lancet ii:762–764
    [Google Scholar]
  11. Mitsuya H., Matis L., Megson M., Bunn P. A., Murray C., Mann D. L., Gallo R. C., Broder S. 1983; Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient with human T cell leukemia/lymphoma virus. Journal of Experimental Medicine 158:994–999
    [Google Scholar]
  12. Moore M. W., Carbone F. R., Bevan M. J. 1988; Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777–785
    [Google Scholar]
  13. Morrison L. A., Lukacher A. E., Braciale V. L., Fan D. P., Braciale T. J. 1986; Differences in antigen presentation to MHC class I- and class 11-restricted influenza virus specific cytolytic T lymphocyte clones. Journal of Experimental Medicine 163:903–921
    [Google Scholar]
  14. Moss B. 1991; Vaccinia virus: a tool for research and vaccine development. Science 252:1662–1997
    [Google Scholar]
  15. Perrin L. H., Zinkernagel R. M., Oldstone M. BA. 1977; Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes. Journal of Experimental Medicine 146:949–969
    [Google Scholar]
  16. Rickinson A. B., Wallace L. E., Epstein M. A. 1981; HLA-restricted T cell recognition of Epstein-Barr virus infected B cells. Nature, London 283:865–867
    [Google Scholar]
  17. Rooney J. F., Wohlenberg C., Cremer K. J., Moss B., Notkins A. L. 1988; Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. Journal of Virology 62:1530–1534
    [Google Scholar]
  18. Tigges M. A., Koelle D., Hartog K., Sekulovich R. E., Corey L., Burke R. L. 1992; Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. Journal of Virology 66:1622–1634
    [Google Scholar]
  19. Walker B. D., Plata F. 1990; Cytotoxic T lymphocytes against HIV. AIDS 4:177–184
    [Google Scholar]
  20. Walker C. M., Erickson A. L., Hsueh F. C., Levy J. A. 1991; Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a non-cytotoxic mechanism. Journal of Virology 65:5921–5927
    [Google Scholar]
  21. Yasukawa M., Inatsuki A., Kobayashi Y. 1989; Differential in vitro activation of CD4+CD8 and CD8+CD4 herpes simplex virus-specific human cytotoxic T cells. Journal of Immunology 143:2051–2057
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-4-751
Loading
/content/journal/jgv/10.1099/0022-1317-74-4-751
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error